Back

Prognostic impact of right ventricular ejection fraction assessed by 3D speckle-tracking echocardiography in patients with dilated cardiomyopathy and ischemic cardiomyopathy

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Three-dimensional echography 3D Echocardiography ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Yasufumi Nagata

Massachusetts General Hospital, Boston (United States of America)

8 More presentations in this session

Presentation thumbnail
Prognostic impact of 3D mitral regurgitant orifice area after Mitraclip implantation
Doctor F. Prevedello (Monselice, IT)
Abstract Slides
Presentation thumbnail
2D and 3D myocardial strain imaging fails to reveal sexual dimorphism of anthracycline-induced cardiotoxicity in long-term survivors of childhood cancers
Doctor V. Li (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Assessment of the role of tgf-beta and 3D echocardiographic evaluation in the early diagnosis of atrial remodelling in elite athletes
Professor N. Ozer (Ankara, TR)
Abstract
Presentation thumbnail
PISA 3D method avoids the requirement of an angle correction factor for mitral valve area assessment in mitral stenosis
Doctor P. Mahia (Madrid, ES)
Abstract
Presentation thumbnail
Impact of left ventricular size and deformational parameters on ejection fraction in patients with hemodialysis: a study using 3-dimensional speckle tracking echocardiography
Doctor T. Yoshizane (Gifu, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Three-dimensional echography

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Why should we use 3D echocardiography?
thumbnail
Congress Presentation
Future of 3D echocardiography in congenital heart disease: role of education, training, and technical development to meet growing requirements of ACHD clinical service
thumbnail
Congress Presentation
Added value of 3D echocardiography for assessment of shunt lesions in adult patients with congenital heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources